Now ideas for wellness

About Meiji

At a Glance

At a Glance

Get to know Meiji at a glance – from our core business to our most important numbers.



Medical needs are always diversifying – here's how Meiji is responding.

Invest in Meiji

The combined strengths of our food and pharmaceutical businesses, plus an emphasis on sustainability, help Meiji deliver long-term growth and stakeholder returns.

Products with the highest market shares in Japan

    • Yogurt
    • No.1
    • 41.2%
    • Market scale 486.5 billion yen
    • *1
    • Chocolate
    • No.1
    • 24.7%
    • Market scale 414.2 billion yen
    • *1
    • Cheese
    • No.3
    • 11.2%
    • Market scale 210.4 billion yen
    • *1
    • Powdered & granulated protein
    • No.1
    • 39.6%
    • Market scale 47.9 billion yen
    • *2
    • Systemic antibacterial drugs
    • No.1
    • 19.0%
    • Market scale 149.2 billion yen
    • *3
    • Influenza HA Vaccine
    • No.1
    • 28.8%
    • Market scale 97.0 billion yen
    • *4
  1. April 2020-March 2021, INTAGE SRI, Market Share in value, Cumulative Sales
  2. Based on Meiji data as of March 2021
  3. Copyright © 2021 IQVIA.
    Calculated based on JPM 2021 Mar MAT
    Market scope as defined by Meiji
    Reprinted with permission
  4. Copyright © 2021 IQVIA.
    Calculated based on JPM 2021 Mar MAT
    Reprinted with permission

Food and pharmaceuticals: strength in synergy

Meiji contributes to health and wellness across a number of market categories including food, nutritional products, and pharmaceuticals. Not only does this give us a broad portfolio, we're able to leverage these different strengths into integrated R&D that creates new health value for consumers and society.

Co-Creation Center
Co-Creation Center


Main areas of business

  • Yogurt & cheese
  • Nutrition
  • Chocolate & gummy
  • Drinking milk
  • Business-to-Business
  • Frozen dessert & ready meal
  • Overseas
  • Other / domestic subsidiaries
  • Domestic ethical pharmaceuticals
  • Overseas ethical pharmaceuticals
  • Human vaccines
  • Agricultural chemicals & veterinary drugs
Graph: Net sales ratio by segment (FY2020)

Net sales ratio by segment (FYE 3/2021)

  • Food Business
  • 84.0%
  • 999.6 billion yen
  • Pharmaceutical Business
  • 16.0%
  • 193.6 billion yen
Graph: Net sales ratio by segment (FY2020)

Net sales ratio by region (FYE 3/2021)

  • Japan
  • 92.7%
  • 136.9 billion yen
  • Overseas
  • 7.3%
  • 37.6 billion yen

Sustainability: a healthier society

Meiji is committed to fulfilling its environmental and social responsibilities. As professionals in food and health, we're uniquely able to contribute to the health and wellness of individuals, which in turn leads to a healthier society and planet. Our environmental and social policies and performance are regularly updated on our main Sustainability page.

Photho:Sustainable Management
Sustainability Management

Improved performance and dividends

The Meiji Group has achieved long-term stable growth and shareholder returns through the sales expansion of core businesses.

Net sales
Graph:Net sales
Return on equity (ROE)
Graph:Return on equity (ROE)
Payout ratio
Graph:Payout ratio

DATA BOOK FY2020—From April, 2020 to March 31, 2021— (PDF 2520KB)

Photo:New slogan
Group Slogan
Photo:Business Plans
Business Plans
Photo:Year in Review
Year in Review